MDSCs are CD11b+Gr1+ cells (CD11b+Ly6G+ or CD11b+Ly6C+) with the ability to prevent T cell activation, and they have been identified in the spleen, blood, and tumor tissues of tumor-bearing mice (21, 33, 34). This evidence concerns the gene ITGAM and neoplasm.